The Effect of Massage on Preterm Babies
Launched by ÖZLEM BOZBUĞA · Jan 23, 2025
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of massage on preterm babies who are receiving a type of breathing support called NCPAP (nasal continuous positive airway pressure) in the Neonatal Intensive Care Unit (NICU). The researchers want to find out if massage can help reduce pain, improve comfort, and enhance feeding for these tiny infants. They believe that by easing stress through massage, babies may have a better experience during their treatment and may face fewer complications.
To participate in this study, infants must be at least 32 weeks old, weigh more than 1500 grams, and have received NCPAP therapy for at least one day. Parents need to agree to take part in the study, and the babies must not have certain health issues, like specific infections or surgeries. If eligible, participants can expect to receive gentle massages as part of their care, and the researchers will closely monitor how this affects their pain levels, comfort, and feeding. This study is not yet recruiting, but it aims to gather important information about how massage might benefit vulnerable preterm infants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Infants of parents who agreed to participate in the study,
- • Receiving NCPAP therapy for at least 1 day,
- • Gestational age greater than 32 weeks
- • Birth weight over 1500 grams
- • Infants fed with orogastric + total parenteral nutrition (TPN) will be included.
- Exclusion Criteria:
- • • Infants with necrotising entecolitis, suspected or confirmed sepsis,
- • No skin disease,
- • Not receiving sedation (considering that it may affect pain response),
- • Babies who have undergone surgical intervention (abdominal and central nervous system, cardiac surgery)
- • Babies of substance-abusing mothers,
- • Infants of parents who do not agree to participate in the study will not be included.
- • Babies in the massage group who switched from Ncpap to IMV, who underwent surgical intervention with sedation and who developed NEC will be excluded from the study.
About özlem Bozbuğa
Özlem Bozbuğa is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on ensuring the highest standards of scientific integrity and ethical compliance, the organization plays a pivotal role in the development of new therapeutic interventions. Özlem Bozbuğa collaborates with a network of leading healthcare professionals and institutions to facilitate rigorous clinical trials that aim to improve patient outcomes and contribute to the global body of medical knowledge. Through meticulous planning and execution, Özlem Bozbuğa strives to enhance the efficiency and effectiveness of clinical research, ultimately benefiting both the medical community and patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
EMİNE ERDEM
Study Chair
TC Erciyes University
OZNUR BASDAS
Study Director
TC Erciyes University
SELVİ GULAŞI
Study Director
Adana City Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported